Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C

Journal of Medical Virology

Volumn 45, Issue 3, 1995, Pages 348-353

  Garson, J A ^a   Whitby, K ^a   Deaville, R ^a   Brillanti, S ^b   Foli, M ^b   Masci, C ^b   Miglioli, M ^b   Barbara, L ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

clinical factors; genotype; hepatitis C; interferon response; quantitative polymerase chain reaction; virological factors

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; ITALY; MALE; POLYMERASE CHAIN REACTION;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERON-ALPHA; PROSPECTIVE STUDIES; RNA, VIRAL;

HEPATITIS C VIRUS;

EID: 0028922390     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.1890450320     Document Type: Article

References (20)

1. The effect of alpha interferon therapy on hepatitis C viraeraia in community acquired chronic non‐A, non‐B hepatitis: a quantitative PCR study
2. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa‐resistant chronic hepatitis C
3. Prediction of sustained remission of chronic hepatitis C after a 12 month course of interferon
4. Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction
5. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial
6. Long‐term clinical and histopathological follow‐up of chronic post‐transfusion hepatitis
7. Improvement of HCV genome detection with “short” PCR products
8. Hepatitis C viraemia rebound after “successful” interferon therapy in patients with chronic non‐A, non‐B hepatitis
9. Genotypes and titers of hepatitis C for predicting response to interferon in patients with chronic hepatitis C
10. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy
11. Avoiding false positives with PCR
12. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
13. Serum hepatitis C virus (HCV)‐RNA and response to alpha‐interferon in anti‐HCV positive chronic hepatitis
14. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease
15. Factors predictive of the response to interferon in patients with chronic hepatitis C
16. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS‐5 regions
17. Typing of HCV isolates and characterisation of new (sub)types using a line probe assay
18. Interferon for non‐A, non‐B chronic hepatitis. A meta‐analysis of randomised clinical trials
19. Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐α therapy: relationship to genotypes of hepatitis C virus
20. Reliability of polymerase chain reaction for the detection of hepatitis C virus